CompletedPHASE1, PHASE2NCT00167219
Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
Studying Juvenile myelomonocytic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Principal Investigator
- Margaret MacMillan, MDMasonic Cancer Center, University of Minnesota
- Intervention
- Stem Cell Transplant(biological)
- Enrollment
- 15 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 1999 – 2023
Study locations (1)
- Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00167219 on ClinicalTrials.govOther trials for Juvenile myelomonocytic leukemia
Additional recruiting or active studies for the same condition.